131 related articles for article (PubMed ID: 8819893)
21. Absence of the sulfate transporter SAT-1 has no impact on oxalate handling by mouse intestine and does not cause hyperoxaluria or hyperoxalemia.
Whittamore JM; Stephens CE; Hatch M
Am J Physiol Gastrointest Liver Physiol; 2019 Jan; 316(1):G82-G94. PubMed ID: 30383413
[TBL] [Abstract][Full Text] [Related]
22. Direct correlation between hyperoxaluria/oxalate stone disease and the absence of the gastrointestinal tract-dwelling bacterium Oxalobacter formigenes: possible prevention by gut recolonization or enzyme replacement therapy.
Sidhu H; Schmidt ME; Cornelius JG; Thamilselvan S; Khan SR; Hesse A; Peck AB
J Am Soc Nephrol; 1999 Nov; 10 Suppl 14():S334-40. PubMed ID: 10541258
[TBL] [Abstract][Full Text] [Related]
23. Effective therapy of enteric hyperoxaluria: in vitro binding of oxalate by anion-exchange resins and aluminum hydroxide.
Laker MF; Hofmann AF
J Pharm Sci; 1981 Sep; 70(9):1065-7. PubMed ID: 6101157
[TBL] [Abstract][Full Text] [Related]
24. Investigation with chitosan-oxalate oxidase-catalase conjugate for degrading oxalate from hyperoxaluric rat chyme.
Ramakrishnan V; Lathika KM; D'Souza SJ; Singh BB; Raghavan KG
Indian J Biochem Biophys; 1997 Aug; 34(4):373-8. PubMed ID: 9491647
[TBL] [Abstract][Full Text] [Related]
25. Oxalate dynamics in chronic renal failure. Comparison with normal subjects and patients with primary hyperoxaluria.
Morgan SH; Purkiss P; Watts RW; Mansell MA
Nephron; 1987; 46(3):253-7. PubMed ID: 3306417
[TBL] [Abstract][Full Text] [Related]
26. Dietary intake, absorption, metabolism, and excretion of oxalate.
Williams AW; Wilson DM
Semin Nephrol; 1990 Jan; 10(1):2-8. PubMed ID: 2404326
[No Abstract] [Full Text] [Related]
27. Food oxalate: factors affecting measurement, biological variation, and bioavailability.
Massey LK
J Am Diet Assoc; 2007 Jul; 107(7):1191-4; quiz 1195-6. PubMed ID: 17604750
[TBL] [Abstract][Full Text] [Related]
28. Transplantation procedures in primary hyperoxaluria type 1.
Latta A; Müller-Wiefel DE; Sturm E; Kemper M; Burdelski M; Broelsch CE
Clin Nephrol; 1996 Jul; 46(1):21-3. PubMed ID: 8832145
[TBL] [Abstract][Full Text] [Related]
29. Enteric hyperoxaluria, nephrolithiasis, and oxalate nephropathy: potentially serious and unappreciated complications of Roux-en-Y gastric bypass.
Nelson WK; Houghton SG; Milliner DS; Lieske JC; Sarr MG
Surg Obes Relat Dis; 2005; 1(5):481-5. PubMed ID: 16925274
[TBL] [Abstract][Full Text] [Related]
30. Impact of dietary calcium and oxalate ratio on urinary stone formation in rats.
Morozumi M; Ogawa Y
Mol Urol; 2000; 4(4):313-20. PubMed ID: 11156697
[TBL] [Abstract][Full Text] [Related]
31. Intestinal hyperabsorption of oxalate in calcium oxalate stone formers: application of a new test with [13C2]oxalate.
Hesse A; Schneeberger W; Engfeld S; Von Unruh GE; Sauerbruch T
J Am Soc Nephrol; 1999 Nov; 10 Suppl 14():S329-33. PubMed ID: 10541257
[TBL] [Abstract][Full Text] [Related]
32. Enteric hyperoxaluria: role of microbiota and antibiotics.
Liu M; Nazzal L
Curr Opin Nephrol Hypertens; 2019 Jul; 28(4):352-359. PubMed ID: 31145706
[TBL] [Abstract][Full Text] [Related]
33. Transport of oxalate across the rabbit papillary surface epithelium.
Chandhoke PS; Fan J
J Urol; 2000 Nov; 164(5):1724-8. PubMed ID: 11025759
[TBL] [Abstract][Full Text] [Related]
34. Hyperoxaluria in patients with idiopathic calcium nephrolithiasis.
Trinchieri A; Ostini F; Nespoli R; Rovera F; Zanetti G; Pisani E
J Nephrol; 1998; 11 Suppl 1():70-2. PubMed ID: 9604817
[TBL] [Abstract][Full Text] [Related]
35. Counteraction of oxalate induced nitrosative stress by supplementation of l-arginine, a potent antilithic agent.
Pragasam V; Kalaiselvi P; Sumitra K; Srinivasan S; Varalakshmi P
Clin Chim Acta; 2005 Apr; 354(1-2):159-66. PubMed ID: 15748613
[TBL] [Abstract][Full Text] [Related]
36. Conjugated bile acid replacement therapy reduces urinary oxalate excretion in short bowel syndrome.
Emmett M; Guirl MJ; Santa Ana CA; Porter JL; Neimark S; Hofmann AF; Fordtran JS
Am J Kidney Dis; 2003 Jan; 41(1):230-7. PubMed ID: 12500242
[TBL] [Abstract][Full Text] [Related]
37. Intestinal oxalate absorption. I. Absorption in vitro.
Caspary WF
Res Exp Med (Berl); 1977 Aug; 171(1):13-24. PubMed ID: 410086
[TBL] [Abstract][Full Text] [Related]
38. Intestinal oxalate-degrading bacteria reduce oxalate absorption and toxicity in guinea pigs.
Argenzio RA; Liacos JA; Allison MJ
J Nutr; 1988 Jun; 118(6):787-92. PubMed ID: 3373343
[TBL] [Abstract][Full Text] [Related]
39. Effect of dietary changes on urinary oxalate excretion and calcium oxalate supersaturation in patients with hyperoxaluric stone formation.
Penniston KL; Nakada SY
Urology; 2009 Mar; 73(3):484-9. PubMed ID: 19118878
[TBL] [Abstract][Full Text] [Related]
40. Oxalate Flux Across the Intestine: Contributions from Membrane Transporters.
Whittamore JM; Hatch M
Compr Physiol; 2021 Dec; 12(1):2835-2875. PubMed ID: 34964122
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]